Related Experiment Video
Updated: May 13, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Virtual screening of chemical libraries for drug discovery
1Director of Computational Chemistry & Informatics GlaxoSmithKline Medicines Research Centre, Stevenage, Department of Computational Chemistry and Informatics, Hertfordshire, SG1 2NY, UK darren.vs.green@gsk.com.
Background:
Virtual screening has become an established tool for lead generation. In recent years, the computational science behind these tools has evolved to become ever more sophisticated and diverse, whilst the quantity of published successes has continued to increase.
Objective:
By understanding the origins of virtual screening, the theoretical limitations behind it, and the published examples of success, to understand the current and potential value of these techniques to drug discovery.
Method:
By reviewing the underlying science and current practice of virtual screening, this article demonstrates the ability of the methods to generate lead molecules.
Conclusion:
Based on current literature and comparison with 'wet' screening techniques such as high-throughput screening and fragment screening, the author suggests areas that need to be addressed if the science of virtual screening is to fulfil its potential.
Related Concept Videos
Drug Discovery: Overview
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

